Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Prolactinoma × ropinirole × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prolactinoma 1 Hyperprolactinemia 1

Interventions

Cabergoline 5 ropinirole 1 pasireotide 1 Tissue Banks 1 Temozolomide 1 Surgical Procedures, Operative 1 Standard of Care 1 Microarray Analysis 1 Magnetic Resonance Spectroscopy 1 Early Intervention, Educational 1 Dopamine Agonists 1 Dexamethasone 1 DNA Methylation 1 Clomiphene 1 Calcium Dobesilate 1 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03038308 2024-06-04

Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole

Columbia University

Phase 1/2 Completed

16 enrolled 8 charts

Hyperprolactinemia, Prolactinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡